Search Results - "Carter, Troy L."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
  2. 2

    Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK by Pedrini, Steve, Carter, Troy L, Prendergast, George, Petanceska, Suzana, Ehrlich, Michelle E, Gandy, Sam

    Published in PLoS medicine (01-01-2005)
    “…Statins are widely used cholesterol-lowering drugs that act by inhibiting HMGCoA reductase, the rate-limiting enzyme in cholesterol biosynthesis. Recent…”
    Get full text
    Journal Article
  3. 3

    Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology by Mishizen-Eberz, Amanda J, Rissman, Robert A, Carter, Troy L, Ikonomovic, Milos D, Wolfe, Barry B, Armstrong, David M

    Published in Neurobiology of disease (01-02-2004)
    “…Alzheimer's disease (AD) is characterized by loss of specific cell populations within selective subregions of the hippocampus. Excitotoxicity, mediated via…”
    Get full text
    Journal Article
  4. 4

    Differential preservation of AMPA receptor subunits in the hippocampi of Alzheimer's disease patients according to Braak stage by Carter, Troy L., Rissman, Robert A., Mishizen-Eberz, Amanda J., Wolfe, Barry B., Hamilton, Ronald L., Gandy, Sam, Armstrong, David M.

    Published in Experimental neurology (01-06-2004)
    “…The Alzheimer's disease (AD) brain, characterized pathologically by the presence of senile plaques and neurofibrillary tangles, contains regions that are…”
    Get full text
    Journal Article
  5. 5

    Brain neprilysin activity and susceptibility to transgene-induced Alzheimer amyloidosis by Carter, Troy L., Pedrini, Steve, Ghiso, Jorge, Ehrlich, Michelle E., Gandy, Sam

    Published in Neuroscience letters (16-01-2006)
    “…Neprilysin (NEP) is a zinc metalloproteinase that degrades enkephalins, endothelins, and the Alzheimer's disease amyloid β (Aβ) peptides. NEP-deficient mice…”
    Get full text
    Journal Article
  6. 6

    Cerebellar AMPA/KA receptor antagonism by CNQX inhibits vestibuloocular reflex adaptation by CARTER, Troy L, MCELLIGOTT, James G

    Published in Experimental brain research (01-10-2005)
    “…Vestibuloocular reflex (VOR) performance and adaptation have been investigated during antagonism of cerebellar AMPA/quisqualate and kainate receptors (AMPA/KA)…”
    Get full text
    Journal Article
  7. 7

    Plasticity of glutamate and GABAA receptors in the hippocampus of patients with Alzheimer's disease by Armstrong, David M, Sheffield, Roxanne, Mishizen-Eberz, Amanda J, Carter, Troy L, Rissman, Robert A, Mizukami, Katsuyoshi, Ikonomovic, Milos D

    Published in Cellular and molecular neurobiology (01-10-2003)
    “…In Alzheimer's disease (AD) it is well known that specific regions of the brain are particularly vulnerable to the pathologic insults of the disease. In…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Physical and chemical considerations in the in vitro calibration of microdialysis probes for biogenic amine neurotransmitters and metabolites by Parry, T J, Carter, T L, McElligott, J G

    Published in Journal of neuroscience methods (01-06-1990)
    “…The object of the present study was to examine the effects of temperature, oxidation, and pH on in vitro relative recovery of catecholamine and indoleamine…”
    Get more information
    Journal Article